View in EDS HTML Full Text PDF Full Text

Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.

Saved in:
Bibliographic Details
Title: Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.
Authors: Ghasoub R; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar., Hamad A; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar., El Akiki S; Diagnostic Genomic Division, Hamad Medical Corporation, Doha, Qatar., Fareed S; Department of BMT & Hematology, NCCCR, Doha, Qatar., Ellahie A; Department of BMT & Hematology, NCCCR, Doha, Qatar., Ismael O; Department of BMT & Hematology, NCCCR, Doha, Qatar., Yassin MA; Department of BMT & Hematology, NCCCR, Doha, Qatar. yassinmoha@gmail.com.
Source: Discover oncology [Discov Oncol] 2025 Oct 23; Vol. 16 (1), pp. 1959. Date of Electronic Publication: 2025 Oct 23.
Publication Type: Journal Article; Review
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41129058
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ghasoub+R%22">Ghasoub R</searchLink>; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Hamad+A%22">Hamad A</searchLink>; Department of Pharmacy, National Center for Cancer Care and Research, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22El+Akiki+S%22">El Akiki S</searchLink>; Diagnostic Genomic Division, Hamad Medical Corporation, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Fareed+S%22">Fareed S</searchLink>; Department of BMT & Hematology, NCCCR, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Ellahie+A%22">Ellahie A</searchLink>; Department of BMT & Hematology, NCCCR, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Ismael+O%22">Ismael O</searchLink>; Department of BMT & Hematology, NCCCR, Doha, Qatar.<br /><searchLink fieldCode="AU" term="%22Yassin+MA%22">Yassin MA</searchLink>; Department of BMT & Hematology, NCCCR, Doha, Qatar. yassinmoha@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101775142%22">Discover oncology</searchLink> [Discov Oncol] 2025 Oct 23; Vol. 16 (1), pp. 1959. <i>Date of Electronic Publication: </i>2025 Oct 23.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer%22">Springer </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101775142 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2730-6011 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227306011%22">27306011 </searchLink><i>NLM ISO Abbreviation: </i>Discov Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41129058
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12672-025-03759-7
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1959
    Titles:
      – TitleFull: Therapeutic positioning of asciminib in chronic myeloid leukemia patients previously treated with multiple tyrosine kinase inhibitors in Qatar.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ghasoub R
      – PersonEntity:
          Name:
            NameFull: Hamad A
      – PersonEntity:
          Name:
            NameFull: El Akiki S
      – PersonEntity:
          Name:
            NameFull: Fareed S
      – PersonEntity:
          Name:
            NameFull: Ellahie A
      – PersonEntity:
          Name:
            NameFull: Ismael O
      – PersonEntity:
          Name:
            NameFull: Yassin MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 23
              M: 10
              Text: 2025 Oct 23
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2730-6011
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Discover oncology
              Type: main
ResultId 1